Citius Pharmaceuticals, Inc. Stock Issued During Period, Shares, Employee Stock Purchase Plans
Citius Pharmaceuticals, Inc. (CTXR) had Stock Issued During Period, Shares, Employee Stock Purchase Plans of 75.00 thousand shares as of 2023-04-10, per its 10-Q filed 2023-08-14.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans · last filed 2023-08-14
- 2023-04-10: Stock Issued During Period, Shares, Employee Stock Purchase Plans 75.00K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans |
|---|---|
| 2023-04-10 | 75.00K shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |